Amulet has closed a $6 million Series A financing round, the company announced recently.

According to a release, the round was led by HealthX Ventures, with participation from Incite Ventures, AllerFund, Mendota Venture Capital, Great Oaks Venture Capital and others.

“Amulet’s technology has the potential to improve the safety of our food systems and, by extension, the health and well-being of millions,” Amulet CEO and Founder Abigail Barnes said in a statement. “From gluten to glyphosate in our food and soil, this funding will allow us to deploy rapid detection for both consumers and businesses to help ensure a safer food supply chain and reduce adverse health outcomes for the food allergy, food intolerant, and celiac populations.”

The funds will help the company scale its team, expand its detection portfolio and execute a full product launch to serve the large and growing Amulet waitlist.